This study was terminated in the United States, in the United Kingdom, and in Russia. It is testing ABT-126 for schizophrenia.
SchizophreniaDrugFrom 20 Years to 66 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether ABT-126 may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive ABT-126, attend study visits with the research team. The registry lists locations in Russia, in the United Kingdom, and in the United States.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Russia · 19 sites
Site Reference ID/Investigator# 117189
Chita
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117188
Kazan'
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117175
Lipetsk
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117159
Moscow
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117183
Moscow
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117182
Novosibirsk
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117157
Saint Petersburg
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117185
Saint Petersburg
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117192
Saint Petersburg
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117193
Saint Petersburg
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117176
Saint Petersburg
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117195
Saint Petersburg
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117186
Saint Petersburg
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117156
Saratov
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117177
Saratov
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117180
Stavropol
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117181
Yaroslavl
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117194
Yekaterinburg
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117178
Yekaterinburg
Site status: Not listed — confirm with the team
United Kingdom · 5 sites
Site Reference ID/Investigator# 117422
Edinburgh
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117423
London
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117425
London
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117424
Newcastle upon Tyne
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 117419
Oxford
Site status: Not listed — confirm with the team
United States · 27 sites
Site Reference ID/Investigator# 95398
Chino, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95381
Costa Mesa, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95400
Escondido, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95406
Garden Grove, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95378
National City, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95390
Norwalk, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95386
Oakland, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95391
Oceanside, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95380
Orange, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95395
Pico Rivera, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95403
Riverside, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 128356
San Bernardino, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95405
San Diego, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95397
San Diego, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95384
San Gabriel, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95385
Santa Ana, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95387
Torrance, California
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95382
New Haven, Connecticut
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95399
Atlanta, Georgia
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95377
Marietta, Georgia
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 120595
Chicago, Illinois
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 129380
Hoffman Estates, Illinois
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95379
Cedarhurst, New York
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95392
Rochester, New York
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95388
Philadelphia, Pennsylvania
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95402
DeSoto, Texas
Site status: Not listed — confirm with the team
Site Reference ID/Investigator# 95393
Houston, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving ABT-126. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 20 Years to 66 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by AbbVie, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
